CannabisNewsWire
Editorial Coverage: As the hemp and CBD markets grow, a wide
variety of CBD- and hemp-based products are becoming available,
including products for pets.
Geyser Brands Inc. (TSX.V: GYSR) (GYSR
Profile) has recently announced an acquisition that
provides the company with two brands of hemp and CBD products.
Indiva Ltd. (TSX.V: NDVA) (OTCQX: NDVAF), which
provides infused products for humans, is working on a new
extraction facility to increase its production. Viridium
Pacific Group (TSX.V: VIR) (OTCQB: VIRFF) is supporting
the growth of the hemp and cannabis industries through investment,
both in acquisitions and in partnership with smaller companies.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF
Profile) has raised the public profile of CBD through
celebrity associations and entry into prestige shops.
Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF)
is producing CBD products for both humans and their furry
companions.
- Hemp and CBD products are now worth billions of dollars each
year and rising.
- Alongside products for humans, ones for pets are
appearing.
- These products are designed to increase the health and
well-being of those who take them.
To view an infographic of this editorial, click here.
Hemp for People and Pets
The hemp industry has come from almost nowhere to become one of
the big business stories of the past ten years. With cultivation,
processing and sales facilities setting up across North America and
beyond, hemp and its extracts are increasingly important products.
People use them for health, well-being and relaxation. Hemp has
even started to feature in foodstuffs and cosmetics.
And as recent industry moves demonstrate, hemp isn’t just for
people. Pet products have also been appearing, promising benefits
such as pain relief, increased energy and broader well-being. Hemp
is now for pets, and companies are moving to make the most of the
opportunity this provides.
Consolidating Hemp
Hemp-based pet products made the news recently thanks to the
acquisition of Solace Management Group Inc., owners of the
Apawthecary Pets product line, by Geyser Brands
Inc. (TSX.V: GYSR).
The acquisition, whose definitive agreement was announced on May
28, represents an important step for Geyser Brands. Providing the
company with more than $2 million in gross revenues, it establishes
Geyser as a leader in the health-focused hemp and CBD industry.
It’s an industry that has grown massively over the past few years
and is continuing to grow. Recent estimates state that CBD and hemp
will exceed $20 billion
in value in the next few years.
Solace, the target of the acquisition, is a significant business
within this market. Its Apothecary Naturals is a leading brand
within the Canadian market, and Apawthecary Pets is one of the few
established brands catering to pets. By leveraging its brands,
intellectual property and proprietary formulations through
licensing and production agreements, Solace has successfully
reached out into pet stores and veterinarian clinics across
Canada.
With a portfolio of 23 products using organic, unrefined,
cold-pressed hemp-seed oil extract, the brands can appeal to
environmentally conscious consumers as well as those wanting
something cleaner to help with their pets’ health. And with a
recent move into a new 7,500-square-foot GMP production facility,
Solace has ensured an ongoing supply of nano-hemp for pets.
Geyser, which is taking Solace’s products to global markets, is
a leading consumer healthcare company, using hemp products to
improve people’s lives. Geyser has its own Health Canada-licensed
CBD production-and-distribution facility and has recently built a
GMP manufacturing base near Vancouver. Like Solace, Geyser has
focused on natural ingredients for its products, making the two
companies a good fit.
But it’s Geyser’s NanoFusion technology that makes the company
stand out. This advanced delivery system quickly and efficiently
transports agents directly to the bloodstream, increasing the
absorption of therapeutic CBD. The insoluble nature of the
molecules means that, for most hemp products, a majority of the
beneficial chemicals are never absorbed. Geyer’s nano-emulsions are
manufactured to improve this absorption, thanks to droplets as
small as a tenth of the size of normal molecules.
The acquisition of Solace might look like just one more in a
series of recent acquisitions in the CBD sector. But for Geyser,
the move is significant. “This is a transformational strategic
acquisition for Geyser, which will establish ourselves as a leading
provider of health-focused hemp and CBD wellness products,” said
Geyser CEO Andreas Thatcher. “With the constant evolution of the
national and international hemp and CBD landscape, and by combining
our expertise in innovation and compliance with Solace’s experience
and market recognition, we will be well placed to capitalize on
what is predicted to be a multibillion-dollar industry.”
Pampering Pets
The opportunity that Geyser is leaping on isn’t just driven by
the rise of hemp — it’s also about broader demographic trends.
Recent decades have seen growth in the middle class around the
world. The growing strength of emerging economies means that more
people across Africa and Asia have wealth to spend on goods beyond
the essentials. And among the nonessentials many adopt are pets.
Pet ownership is growing around the world, and
that growth increases the demand for the items needed that come
with owning a pet, including grooming, toys and food.
At the same time, concerns about health and chemicals that are
consumed are on the rise. Awareness of environmental issues has
spurred waves of protest, a swing toward green parties in recent
European elections, and booming sales for locally and organically
produced foods. As individual consumers, many people are trying to
avoid manmade chemicals, both for the sake of the environment and
for their own health. That concern now extends to feeding and
caring for pets, with owners looking for more natural ways to
support their furry companions. And that’s where the CBD products
of companies such as Geyser come in.
Apawthecary Pets
provides a range of CBD treats and oral drops designed to improve
the health and well-being of dogs. These products have helped
owners treat pain, anxiety
and seizures, making life better for their pets. And now the
company is adding a new brand,
WildTails, with a range of treats for both dogs and cats.
Freeze-dried meat treats infused with hemp or CBD, these products
minimize processing and the addition of extra ingredients to make a
snack that is both natural and good for pets.
Given the growing wealth of the Asian middle class, it’s not
surprising that companies are looking to that continent as a major
market for this type of product. Starting with the
negotiation of orders and distribution contracts in Asia,
Geyser’s release of WildTails is reaching a market beyond CBD’s
core territory of North America.
Part of a Bigger Picture
Just as CBD isn’t just for humans, the infusing of food isn’t
just for pets.
Companies such as Indiva Ltd. (TSX.V: NDVA) (OTCQX:
NDVAF) have developed ranges of edible products targeted
at humans and infused with CBD. These are part of a wider range of
products in which cannabinoids, the active ingredients in cannabis,
are introduced to food as an alternative way of consuming them. CBD
is one of the two leading cannabinoids, alongside psychoactive THC,
and Indiva offers products infused with one or both of these
ingredients. The company is currently developing an
extraction facility that will improve its ability to extract
these natural chemicals from plants and put them into food.
The work of hemp and cannabis producers is supported by
companies such as Viridium Pacific Group (TSX.V: VIR)
(OTCQB: VIRFF). Viridium is a Canadian public capital
company that has invested heavily in the cannabis industry,
developing several wholly owned subsidiaries. In addition to
production and distribution of cannabis, the company is involved in
related property development and resource management. Like Geyser,
Viridium is making use of mergers and acquisitions as well as
collaborating with other companies in the sector. One of its
subsidiaries recently supplied plant
clones to one of Canada’s first micro-cultivators, helping the
smaller business to establish its own crops.
A Vancouver-based health and wellness company,
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
is focused heavily on CBD. It produces capsules, tinctures,
vaporizing liquids and other CBD-infused products. Aiming at an
upmarket clientele, several of its products have achieved a
prestigious status through their recent appearances at Kim
Kardashian’s baby shower, in hotel swag bags for the Oscars and in
the Saks Fifth Avenue store. The company is also reaching a wider
audience, with the acquisition of City
Cannabis providing more outlets in Canada.
Phivida Holdings Inc. (CSE: VIDA) (OTCQX:
PHVAF) is firmly focused on functional food and beverages,
a broad description for those containing active ingredients such as
THC and CBD, with a particular focus on the health and well-being
sector. The OKI product line is set to make beverages a central
part of the business, as CBD drinks offer consumers an alternative
recreational beverage to alcohol and caffeine. The company has also
announced a line of CBD-infused
products for pets, initially consisting of tinctures and an
oral spray.
With the CBD market growing alongside that for pet products,
it’s natural that the two should combine as the focus to serve
expands to humans and their well-loved pets.
For more information on Geyser Brands, visit Geyser Brands
Inc. (TSX.V: GYSR)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides
(1) access to our news aggregation and syndication servers, (2)
CannabisNewsBreaks that summarize
corporate news and information, (3) enhanced press release
services, (4) social media distribution and optimization services,
and (5) a full array of corporate communication solutions. As a
multifaceted financial news and content distribution company with
an extensive team of contributing journalists and writers, CNW is
uniquely positioned to best serve private and public companies that
desire to reach a wide audience of investors, consumers,
journalists and the general public. CNW has an ever-growing
distribution network of more than 5,000 key syndication outlets
across the country. By cutting through the overload of information
in today’s market, CNW brings its clients unparalleled visibility,
recognition and brand awareness. CNW is where news, content and
information converge.
Receive Text Alerts
from CannabisNewsWire: Text "Cannabis" to
21000
For more information please visit https://www.CannabisNewsWire.com and
or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the
CannabisNewsWire website applicable to all content provided by CNW,
wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by CNW are
solely those of CNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable CNW for any investment
decisions by their readers or subscribers. CNW is a news
dissemination and financial marketing solutions provider and is NOT
registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, CNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and CNW undertakes no
obligation to update such statements.
Source:
CannabisNewsWire
Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
Phivida (CSE:VIDA)
Historical Stock Chart
From Oct 2024 to Nov 2024
Phivida (CSE:VIDA)
Historical Stock Chart
From Nov 2023 to Nov 2024
